Study of E7386 in Participants With Selected Advanced Neoplasms
NCT03264664
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Neoplasms
Interventions
DRUG:
E7386
Sponsor
Eisai Inc.